TABLE 63Classification of reported adverse effects: Clavien IVa

StudyReported adverse effect(s)
Carlsson 2010104Pulmonary embolism, myocardial infarction
Dahl 2009126Pulmonary embolism
Ficarra 2009106Re-exploration due to bleeding
Hu 200692Pulmonary embolism, myocardial infarction, cerebral vascular accident, acute tubular necrosis
Krambeck 2009108Pulmonary embolism, renal failure, myocardial infarction, stroke
Lama 2009133Embolic stroke
Poulakis 2007137Cardiovascular including arrhythmias and myocardial infarction, respiratory insufficiency
Rozet 200796Pulmonary embolism, renal insufficiency
Salomon 2002140Pulmonary embolism
Tewari 2003116Myocardial infarction

From: Appendix 10, Classification of reported adverse effects using the Clavien–Dindo classification of surgical complications

Cover of Systematic Review and Economic Modelling of the Relative Clinical Benefit and Cost-Effectiveness of Laparoscopic Surgery and Robotic Surgery for Removal of the Prostate in Men with Localised Prostate Cancer
Systematic Review and Economic Modelling of the Relative Clinical Benefit and Cost-Effectiveness of Laparoscopic Surgery and Robotic Surgery for Removal of the Prostate in Men with Localised Prostate Cancer.
Health Technology Assessment, No. 16.41.
Ramsay C, Pickard R, Robertson C, et al.
Southampton (UK): NIHR Journals Library; 2012 Nov.
© 2012, Crown Copyright.

Included under terms of UK Non-commercial Government License.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.